An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).
C.-A. Moulton,
Mark N. Levine,
CC Law,
Rebecca Hart,
Leyo Ruo,
Chu‐Shu Gu,
Aaron Hendler,
Karen Y. Gulenchyn,
Mintallah Haider,
Michael Marcaccio,
Journal of Clinical Oncology · 2011 · 13 citations · 0 references